adverse effects

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement

Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.

Effect: improvement